Skip to content
Screener

Pacira BioSciences, Inc. PCRX Lease Liability Payments - Remainder of Fiscal Year

Lease Liability Payments - Remainder of Fiscal Year at other companies

Ameresco logo
AmerescoAMRC
$1.65M-11.1%
nCino, Inc. logo
nCino, Inc.NCNO
$3.07M-12.1%
REX American Resources logo
REX American ResourcesREX
$352K-93.9%
Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
$300.12K+3.0%
Amalgamated Financial Corp. logo
Amalgamated Financial Corp.AMAL
$1.94M-78.2%
Alpha and Omega Semiconductor logo
Alpha and Omega SemiconductorAOSL
$286K0.0%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$973.83M-14.0%
Enterprise value$1.24B+4.9%
P/E189.5×—
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths.

The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028871
YearAggregate Minimum Payments Due
2026 (remaining nine months)$9,505
202712,298
202811,150
202911,038
20305,839
Thereafter432
Total future lease payments50,262
Less: imputed interest(6,739)

Item 1. FINANCIAL STATEMENTS (Unaudited)

FAQ

What is Pacira BioSciences, Inc.'s lease liability payments - remainder of fiscal year?
Pacira BioSciences, Inc. (PCRX) reported lease liability payments - remainder of fiscal year of $12.3M in Q1 2026.
How has Pacira BioSciences, Inc.'s lease liability payments - remainder of fiscal year changed year-over-year?
Pacira BioSciences, Inc.'s lease liability payments - remainder of fiscal year decreased by 3.7% year-over-year, from $12.77M to $12.3M.
What does lease liability payments - remainder of fiscal year mean?
The contractual cash obligations for operating and finance leases due within the remaining months of the current fiscal year. This provides a short-term view of the company's fixed lease commitments. It is a critical component for assessing near-term liquidity and cash flow requirements.

Ask your AI about Pacira BioSciences, Inc.'s lease liability payments - remainder of fiscal year.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude